Biotech & Health
Pfizer 2026 Forecast Raised as Eliquis Sales Jump 25%
Pfizer raised its full-year revenue and earnings forecasts after stronger Eliquis and cancer-treatment sales supported third-quarter results. The company now expects up to $64 billion in annual revenue despite declining COVID-19 product sales.